Status:
COMPLETED
Intraarticular Antibiotic in TKA
Lead Sponsor:
Washington University School of Medicine
Conditions:
Antibotics in Cementless Knees
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of the study is to determine the intra-articular concentration of vancomycin and tobramycin after administration of vancomycin and tobramycin powder in primary cementless total knee arthro...
Detailed Description
Patients will be identified by medical record review to make sure they meet inclusion and exclusion criteria. Patients that qualify and sign consent will have tobramycin and vancomycin antibiotic powd...
Eligibility Criteria
Inclusion
- Age over 18
- Total knee arthroplasty for primary osteoarthritis. Primary diagnosis of knee osteoarthritis
Exclusion
- Diminished mental capacity
- Vancomycin allergy
- Tobramycin allergy
- Chronic kidney disease stage III and stage IV
Key Trial Info
Start Date :
February 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04297631
Start Date
February 14 2020
End Date
November 1 2020
Last Update
October 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110